1. Home
  2. FLYE vs CELZ Comparison

FLYE vs CELZ Comparison

Compare FLYE & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fly-E Group Inc.

FLYE

Fly-E Group Inc.

N/A

Current Price

$1.60

Market Cap

4.1M

Sector

Industrials

ML Signal

N/A

Logo Creative Medical Technology Holdings Inc.

CELZ

Creative Medical Technology Holdings Inc.

HOLD

Current Price

$0.41

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLYE
CELZ
Founded
2018
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
4.6M
IPO Year
2024
2008

Fundamental Metrics

Financial Performance
Metric
FLYE
CELZ
Price
$1.60
$0.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 665.4K
79.0K
Earning Date
11-13-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 61.82
32.08
EPS
N/A
★ N/A
Revenue
★ $19,063,357.00
$6,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.22
$0.44
52 Week High
$109.00
$4.72

Technical Indicators

Market Signals
Indicator
FLYE
CELZ
Relative Strength Index (RSI) 40.43 22.17
Support Level $1.29 N/A
Resistance Level $1.92 $2.39
Average True Range (ATR) 0.26 0.05
MACD -0.06 -0.01
Stochastic Oscillator 0.00 0.95

Price Performance

Historical Comparison
FLYE
CELZ

About FLYE Fly-E Group Inc.

Fly-E Group Inc is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters, and related accessories under the Fly E-Bike brand. It offers 27 E-motorcycle products, 37 E-bike products and 38 E-scooter products.

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.

Share on Social Networks: